author-photo

Dean A. Fennell

University of Leicester
University Hospitals of Leicester NHS Trust

202

Papers

6687

Citations

Citation Trend

Filter By

Papers (136) Sort By

Journal Conference Others

A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
A phase II trial of abemaciclib in patients with p16ink4a negative, relapsed mesothelioma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (11)
Precision Therapy for Mesothelioma: Feasibility and New Opportunities

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Durable Response to Vismodegib in PTCH1 F1147fs Mutant Relapsed Malignant Pleural Mesothelioma: Implications for Mesothelioma Drug Treatment

2021
Show All
- Source
- Cite
- Save
Citations (2)
Promising Investigational New Drugs for Mesothelioma: What Is the Next Stage of the Treatment for Advanced Mesothelioma?

2021
- Dean A. Fennell
Show All
- Source
- Cite
- Save
Citations (0)
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (12)
P198 Thoracic skeletal muscle loss is prognostic in malignant pleural mesothelioma

2021 Thorax
Show All
- Source
- Cite
- Save
Citations (0)